Innovent Biologics Technology Limited (Shanghai R&D Center)
Innovent Biologics Technology Limited (Shanghai R&D Center)
Explore linked clinical trials.5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tigulixostat (IBI128) vs Febuxostat in Gout | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Nutritional and Metabolic Diseases, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Active, not recruiting | Phase 3 | 2026-09-01 | NCT07414394 | |
| A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema（DME） | Diabetic Macular Oedema | Active, not recruiting | Phase 2 | 2026-05-27 | NCT06908876 | |
| This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors | Solid Tumor | Recruiting | Early phase 1 | 2026-02-04 | NCT07327632 | |
| A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD | Neovascular Age-related Macular Degeneration | Recruiting | Phase 2 | 2026-01-08 | NCT07275840 | |
| A Study of IBI3032 in Chinese Participants With Overweight or Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 1 | 2025-12-31 | NCT07170319 |